Skip to content
Four climbers in winter gear stand at a snowy summit, celebrating their ascent. Three individuals hold a blue banner that reads "OCRA Ovarian Cancer Research Alliance." The background shows a panoramic view of snow-capped peaks and a clear, blue sky.

Ovarian Cancer Research Alliance

(Upcoming Webinar) Ask the Experts: Gynecologic Clear Cell Carcinoma

Learn more and ask questions live at this webinar focused on research, treatment, and survivorship. March 25th at 1PM ET. Registration is free.

Register

Only OCRA combines a laser focus with a panoramic view.

Funding Breakthrough Research

OCRA has invested $140 million toward finding a cure for ovarian and gynecologic cancers.

Discover our research

Supporting You Every Step of The Way

OCRA’s groundbreaking patient support programs help more than 110,000 people each year navigate an overwhelming diagnosis, aiding patients and families when they need it most.

Find support

Advocacy is the Lifeblood of Change

OCRA advocates on Capitol Hill to improve research and education, drug and diagnostic safety, and access to quality care for all members of the ovarian and gynecologic cancer community. To date, OCRA has helped secure more than $3.8 billion in federal funding.

Take action now
A woman wearing sunglasses and a gray shirt kisses a small child on the lips. The child, dressed in a yellow shirt with a Disney character and a yellow bow in her hair, looks content. They are outdoors with trees and greenery in the background.

Genetic testing can save your life.

Knowledge is power. Genetic testing can lower your risk of ovarian and gynecologic cancers.

Find out more

The power of shared experiences

Join our Staying Connected Support Series, Woman to Woman Peer Mentor Program, or online community for knowledge, connection, support, and hope.

Find support

A Message from President and CEO Audra Moran

Get Involved

Join us as we drive innovation, offer hope, and invest in groundbreaking research that saves lives.

There are so many ways to lend a hand and improve the lives of thousands of ovarian and gynecologic cancer patients and their families.

Get involved

News & Updates

Global Ovarian Cancer Research Consortium Awards Inaugural AI Accelerator Grant with Microsoft’s AI for Good Lab

Global Ovarian Cancer Research Consortium Awards Inaugural AI Accelerator Grant with Microsoft’s AI for Good Lab

$1 million global research award, plus an additional $1 million in compute support, advances AI-driven efforts to personalize ovarian cancer care The Global Ovarian Cancer Research Consortium today awarded its inaugural AI Accelerator Grant to an international team of researchers to examine whether artificial intelligence (AI) can improve how survival and treatment response are predicted … Continued

Read more

FDA Approves First Ovarian Cancer Immunotherapy for PD-L1–Positive Platinum-Resistant Disease

FDA Approves First Ovarian Cancer Immunotherapy for PD-L1–Positive Platinum-Resistant Disease

The U.S. Food and Drug Administration (FDA) has approved the first immunotherapy regimen shown to extend survival in a subset of ovarian cancer patients.  The FDA authorized Keytruda (pembrolizumab), made by Merck, in combination with chemotherapy, for PD-L1–positive, platinum-resistant epithelial ovarian, fallopian tube, and primary peritoneal cancers. Keytruda plus weekly Taxol (paclitaxel), with or without … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.